Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : AMIGOS INVITATIONAL YEEHAW PORTFOLIO -- Ignore unavailable to you. Want to Upgrade?

To: James Strauss who wrote (889)	8/8/1999 4:07:00 PM
From: majormember	Read Replies (1) \| Respond to of 1316

>>>>>Do you suppose if KNT had a loss the stock would have gone up? Jim, Actually, KNT seemed to have a quite normal reaction, price moved to $19, B/4 earnings, then sold off some when they met eps. >>>>>:< Strange market... : > My life time achievement award goes to SNRS for having the best pre-FDA P/R (both eyes-same day) with the worst outcome, Unanimus ODP rejection. Add to that the short interest going ballistic the day before the panel; the WSJ front paging the clinical investigator's holding major chunks of the co. the day before, and at least 50% of the ODP having a financial stake of some sort in VISX.......Where's Columbo when you need him: Message 10788233 Skane P.S. if KNT does not appreciate +10 pts this week, I'm out